Cargando…
Albendazole repurposing on VEGFR-2 for possible anticancer application: In-silico analysis
Drug repurposing is the finding new activity of the existing drug. Recently, Albendazole’s well-known antihelmintic has got the attention of an anticancer drug. Plausible evidence of the interaction of Albendazole with one of the types of tyrosine kinase protein receptor, vascular endothelial growth...
Autores principales: | Gaikwad, Nikita Maruti, Chaudhari, Pravin Digambar, Shaikh, Karimunnisa Sameer, Chaudhari, Somdatta Yashwant, Saleem, Rasha Mohammed, Algahtani, Mohammad, Altyar, Ahmed E., Albadrani, Ghadeer M., Kamel, Mohamed, Abdel-Daim, Mohamed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431642/ https://www.ncbi.nlm.nih.gov/pubmed/37585409 http://dx.doi.org/10.1371/journal.pone.0287198 |
Ejemplares similares
-
Dietary Thymoquinone Alone or Combined with Swimming Exercise Protect against Microcystin-LR-Induced Oxidative Injury in Mice
por: Altyar, Ahmed E., et al.
Publicado: (2023) -
Recognizing novel drugs against Keap1 in Alzheimer’s disease using machine learning grounded computational studies
por: Mukerjee, Nobendu, et al.
Publicado: (2022) -
Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer’s disease
por: Debnath, Sandip, et al.
Publicado: (2023) -
Formulation of ciprofloxacin-loaded oral self-emulsifying drug delivery system to improve the pharmacokinetics and antibacterial activity
por: Asghar, Asghar Ali, et al.
Publicado: (2022) -
In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators
por: Zaki, Magdi E. A., et al.
Publicado: (2023)